Skip to content

AJOB Neuroscience

ISSN 2150-7740, 2150-7759

35 papers in the library · 135 citations · publishing 2018-2026

Papers

Sort Most recent Most cited

Consciousness and Human Brain Organoids: A Conceptual Mapping of Ethical and Philosophical Literature.

AJOB Neuroscience July 9, 2025 Aileen Van Gyseghem, Kris Dierickx, Andrew J Barnhart 17 citations

Human brain organoids (HBOs) are three-dimensional structures derived from human pluripotent stem cells that model aspects of fetal brain development. As HBO models grow more complex, ethical concerns arise, particularly around the potential for consciousness. Defining and detecting consciousness in HBOs remains unresolved, with existing theories offering conflicting predictions. This...

DOI: 10.1080/21507740.2025.2519459 (opens in new tab) Full text (opens in new tab) Human brain organoids Lab-grown brain models Organoid intelligence Bioethics +7

Authenticity and Love Drugs: Insights from Psychedelic Therapy.

AJOB Neuroscience June 16, 2025 Owen Thomas, Francisca Silva

In "Prescription for Love: An Experimental Investigation of Laypeople's Relative Moral Disapproval of Love Drugs," Lantian, Boudesseul, and Cova (2024) explore the moral implications of hypothetical romantic love-enhancing biotechnological interventions. Their study reveals "love drugs" (LDs) are viewed as less acceptable than psychological therapy due to the perceived inauthenticity of the...

Strong Bipartisan Support for Controlled Psilocybin Use as Treatment or Enhancement in a Representative Sample of US Americans: Need for Caution in Public Policy Persists

AJOB Neuroscience February 5, 2024 Julian D. Sandbrink, Kyle Johnson, Maureen Gill et al. 13 citations

The psychedelic psilocybin has shown promise both as treatment for psychiatric conditions and as a means of improving well-being in healthy individuals. In some jurisdictions (e.g., Oregon, USA), psilocybin use for both purposes is or will soon be allowed and yet, public attitudes toward this shift are understudied. We asked a nationally representative sample of 795 US Americans to evaluate the...

Journey to Narayama: Cultural Complexities, Psychedelics and Dementia

AJOB Neuroscience April 3, 2023 R. Ozeki-Hayashi, D. Wilkinson

In their target article, Peterson et al. discuss the intriguing prospect of using psychedelics as a treatment for patients with Alzheimer’s Disease and Related Dementias (AD/ADRD) (Peterson et al. 2023). They provide a helpful analysis of ethical issues that may arise in research or clinical use. However, while they mention the use of psychedelics in indigenous spiritual practices, Peterson et...

Psychedelic Research for Dementia Risks Perpetuating Structural Failures and Inadequacies in Aged Care

AJOB Neuroscience April 3, 2023 Hojjat Soofi, C. Forlini

Carhart-Harris, R., B. Giribaldi, R. Watts, M. Baker-Jones, A. Murphy-Beiner, R. Murphy, J. Martell, A. Blemings, D. Erritzoe, D. J. Nutt, et al. 2021. Trial of psilocybin versus escitalopram for depression. New England Journal of Medicine 384 (15):1402–11. doi:10.1056/NEJMoa 2032994. Coulson, A. 2023. Lecanemab approved for use by US FDA. NeuroCentral, 19 Jan. https://www.neuro-central.com/...

Searching for Consciousness in Unfamiliar Entities: The Need for Both Systematic Investigation and Imagination

AJOB Neuroscience April 3, 2023 Sarah Diner, Maxence Gaillard

10.1080/21507740.2022.2048726. Stoekl e, H. C., A. Ivasilevitch, G. Marignac, and C. Herv e. 2021. Creation and use of organoids in biomedical research and healthcare: The bioethical and metabioethical issues. Cell Adhesion & Migration 15 (1):285–94. doi: 10.1080/19336918.2021.1996749. Stoekl e, H. C., L. Ladrat, T. Landrin, P. Beuzeboc, and C. Herv e. 2022. Bio-ethical issues in oncology...

Artificial Consciousness Is Morally Irrelevant

AJOB Neuroscience April 3, 2023 B. Blackshaw

It is widely agreed that possession of consciousness contributes to an entity’s moral status. Therefore, if we could identify consciousness in a machine, this would be a compelling argument for considering it to possess at least a degree of moral status. However, as Elisabeth Hildt explains, our third person perspective on artificial intelligence means that determining if a machine is conscious...

The Road to Ixtlan in Neuro-Degenerative Diseases Is Paved with Palliative Cobblestones

AJOB Neuroscience April 3, 2023 Christopher Poppe, Manuel Trachsel

Aday, J. S., C. C. Davoli, and E. K. Bloesch. 2019. 2018: A watershed year for psychedelic science. Drug Science, Policy and Law 5. doi:10.1177/2050324519872284. Chapman, M., J. Philip, and P. Komesaroff. 2019. Towards an ecology of dementia: A manifesto. Journal of Bioethical Inquiry 16 (2):209–16. doi:10.1007/s11673-01909910-8. Cunningham, C., S. Macfarlane, and H. Brodaty. 2019. Language...

Implications from Jaworska’s Account of Autonomy and Self for Dementia and Psychedelic Research

AJOB Neuroscience April 3, 2023 Zak A. Kopeikin

Peterson et al. (2023) write that there’s “a rich philosophical debate on the nature of authenticity in dementia” involving the relationship of identity and autonomy. I explore this with Jaworska’s theory of autonomy and self. First, I introduce Jaworska’s conceptions. Then, I apply Jaworska’s theory to psychedelic research involving people with Alzheimer’s disease and related dementias...

Extended Mind Over Matter: Privacy Protection Is the Sine Qua Non

AJOB Neuroscience April 3, 2023 Cohen Marcus Lionel Brown

Palermos’s (2023) concept of “mental data” is appreciated as advancing fresh considerations in urgent discourse on mental privacy. However, it is suggested that the proposal for an ontologically distinct category of mental data as currently drafted is nongenerative of novel privacy measures. I agree that mind-related data pose nascent risks—but not because they constitute part of the mind. This...

Avoiding the Premature Introduction of Psychedelic Medicines in Alzheimer’s Disease and Related Disorders

AJOB Neuroscience April 3, 2023 A. Carter, Myfanwy Graham, W. Hall et al.

informed consent to psychedelic-assisted psychotherapy. Johnson, M. W. 2021. Consciousness, religion, and gurus: Pitfalls of psychedelic medicine. ACS Pharmacology & Translational Science 4 (2):578–81. doi:10.1021/acsptsci. 0c00198. Herzberg, G., K. Conour, J. Butler, A. Emerson, L. S. Gillooly, V. Gold, M. Hayes, L. Mix, and E. Sienknecht. 2019. Towards an ethos of equity and inclusion in the...

Publishing the Biotechnical Futures of Alzheimer’s Disease

AJOB Neuroscience April 3, 2023 J. Fletcher

In “Journeying to Ixtlan,” Peterson and colleagues (2023) evaluate some of the potential ethical implications of treating Alzheimer’s disease (AD) with psychedelic medicines. In this commentary, I suggest a need to critically engage with such bioethical appraisals of promissory biotechnologies because, whether deliberately or inadvertently, they often have a biopolitical function and perform...

Barriers and Facilitators to the Equitable Access of Psychedelic Medical Care and Research in Alzheimer’s Disease and Related Dementias

AJOB Neuroscience April 3, 2023 Kai Rudolph

Beauchamp, T. L., and J. F. Childress. 2019. Principles of biomedical ethics. Oxford: Oxford University Press. Boyle, J. 2004. Medical ethics and double effect: the case of terminal sedation. Theoretical Medicine and Bioethics 25 (1):51–60. doi:10.1023/b:meta.0000025096.25317.22. Creutzfeldt, C. J., B. M. Kluger, and R. G. Holloway. 2019. Neuropalliative care: A guide to improving the lives of...

Symbolic Value of Brain Organoids: Shifting the Focus from Consciousness to Sociocultural Perspectives on Resemblance

AJOB Neuroscience April 3, 2023 S. A. L. van Till, E. Bunnik

Kalichman, E. Thompson, L. Goldstein, C. Koch, and A. R. Muotri. 2022. Brain organoids, consciousness, ethics and moral status. Seminars in Cell & Developmental Biology. doi:10.1016/j.semcdb.2022.03.020. Lagercrantz, H. 2014. The emergence of consciousness: Science and ethics. Seminars in Fetal & Neonatal Medicine 19 (5):300–5. doi:10.1016/j.siny.2014.08.003. Monasterio Astobiza, A., and A....